RBC raised HCA Healthcare target from USD 435 to USD 496 for HCA Healthcare stock

Published on 10/23/2026 at 10:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

HCA Healthcare stock costs EUR 413.60 on October 23, 2026. Revenue reached USD 20.23 billion before the October 27 call.

Target revision and earnings test

RBC set a USD 496.00 target on October 7, 2026, up from USD 435.00.
Second-quarter revenue reached USD 20.23 billion, while third-quarter consensus revenue is USD 19.33 billion.
HCA Healthcare stock trades at EUR 413.60 at 10:36 a.m. CEST at Lang & Schwarz on October 23, 2026.
The next earnings call is scheduled for October 27, 2026, at 10:00 a.m. ET.
Market capitalization stood at USD 101.2 billion as of October 22, 2026.

Isometrische 3D-Illustration der Krankenhaus-Wertschöpfungskette: Aufnahme, Diagnose, OP, Pflege, Apotheke — HCA Healthcare US40412C1018 isometrisches Diagramm der Wertschöpfungskette vom Patienten über Diagnose bis zur Apotheke, Illustration mit AI erstellt.

HCA Healthcare (ISIN US40412C1018) was trading at EUR 413.60 at Lang & Schwarz on October 23, 2026, at 10:36 a.m. CEST. The latest analyst action came from RBC, which raised its price target from USD 435.00 to USD 496.00 on October 7, 2026, according to MarketScreener.

RBC raises the valuation bar

RBC kept an Outperform rating alongside the new target, giving investors a concrete benchmark ahead of HCA Healthcare's third-quarter report. The target revision followed HCA Healthcare's second-quarter performance, when revenue reached USD 20.23 billion and diluted earnings per share were USD 7.62 for the quarter ended June 30, 2026.

MarketBeat reports that the next quarter is expected to produce USD 6.65 in earnings per share on USD 19.33 billion of revenue. The comparison is demanding: the year-earlier quarter produced USD 6.96 in earnings per share on USD 19.16 billion of revenue.

Three dated HCA milestones

On July 24, 2026, HCA Healthcare reported second-quarter revenue of USD 20.23 billion and diluted earnings per share of USD 7.59, according to MarketBeat. On October 7, 2026, RBC lifted its target from USD 435.00 to USD 496.00. On October 27, 2026, HCA Healthcare is scheduled to discuss third-quarter results.

What will the October 27 call test?

The central question is whether admissions and pricing can support revenue while expenses remain elevated. Yahoo Finance reported that the consensus forecast for equivalent admissions implies 1.70 percent year-over-year growth, while occupancy is expected at 73.00 percent versus 71.70 percent a year earlier. The same report cited a 4.30 percent consensus increase in inpatient revenue per admission.

Next scheduled investor date

HCA Healthcare announced on September 30, 2026, that its third-quarter earnings call will take place on October 27, 2026, at 10:00 a.m. ET. The scheduled event is the next dated catalyst in the company calendar.

Stock price and valuation context

HCA Healthcare was valued at USD 101.2 billion as of October 22, 2026. Its NYSE price was USD 467.31 at 4:00 p.m. EDT on October 22, 2026, and the 52-week range was USD 353.99 to USD 556.52. The euro quotation provides the German-market perspective, while the upcoming report will test the operating figures behind the valuation.

HCA Healthcare was trading at EUR 413.60 at Lang & Schwarz on October 23, 2026, at 10:36 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of HCA Healthcare stock.